Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REPOSE: Suvorexant for Postoperative Sleep and Delirium
NCT05733286Phase 2Completed
- Sponsor
- Duke University
- Start
- Jun 2023
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in delirium comparing Suvorexant Arm with Placebo Arm (2 arms). Primary endpoint: Total Sleep Time at Day 0. Started Jun 2023; status: completed.
02
Drugs
suvorexant
03
Conditions
delirium
Beyond the preview
Go deeper on NCT05733286.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05733286.